Norcape Biotechnology

Norcape Biotechnology is a Norwegian industrial biotechnology company focused on developing and marketing patented bioprocessing technologies rather than therapeutics. Its patent estate and public descriptions indicate work on hydrolyzed marine protein products, feed and culture-medium ingredients, and processing methods for krill and other marine raw materials. The company appears to have operated alongside DUE MILJØ, which supplies membrane and separation systems for the process and food industries. In February 2020, Eagle Technology acquired all shares in Norcape Biotechnology AS and DUE MILJØ AS. Based on available evidence, Norcape is better characterized as an industrial or marine biotechnology company than as a drug-development biotech.